Resting-state EEG changes associated with cognitive decline in Parkinson’s disease: a systematic review
Journal of Neural Transmission · 2026-04 · 133 (4) · 731-765
DOI: 10.1007/s00702-025-03065-0 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Neural Transmission, online erschienen am 18.11.2025. Verfasst von Milena Spoa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Padova Neuroscience Center, University of Padova, Padua, Italy. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Parkinson Disease, Electroencephalography. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Padova.
Abstract (Originalsprache)
Cognitive decline is a common and disabling feature of Parkinson’s disease (PD), frequently progressing from mild cognitive impairment to Parkinson’s disease dementia. Due to substantial heterogeneity in PD phenotypes, current research is increasingly focused on identifying robust biomarkers to predict which individuals are at higher risk of cognitive deterioration relative to those likely to exhibit cognitive stability. Electroencephalography (EEG), a non-invasive and cost-efficient method for measuring neural activity, has shown potential in detecting early electrophysiological alterations associated with cognitive decline in PD. This review aims to summarise recent findings on the utility of resting-state quantitative EEG measures as candidate biomarkers for cognitive trajectory in PD. Relevant studies from over the last 10 years were retrieved through PubMed and Scopus, resulting in the inclusion and evaluation of 67 articles. Distinct EEG features, identified using various analytic approaches, were found to discriminate PD patients across different cognitive stages, as well as from those cognitively unimpaired and healthy controls. We suggest that EEG surrogate markers may be a valuable tool in conjunction with clinical and genetic variables to help early detection and monitoring, as well as development of personalised interventions for cognitive impairment in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Padova Neuroscience Center, University of Padova, Padua, Italy.
- Human Neuroscience Group, Centre for Neuroscience and Neuromodulation, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.
- Department of Information Engineering, University of Padova, Padua, Italy.
- Neurodegenerative Disease Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, Padua Neuroscience Center (PNC), University of Padova, Padua, Italy.
- Neurodegenerative Disease Unit, Centre for Rare Neurological Diseases (ERN-RND), Department of Neuroscience, Padua Neuroscience Center (PNC), University of Padova, Padua, Italy. angelo.antonini@unipd.it.
- IRCCS San Camillo, Venice, Italy. angelo.antonini@unipd.it.
Förderung
- Università degli Studi di Padova
Zitieren
APA
Spoa, M., Monti, S., Bjekić, J., Guerra, A., Fiorenzato, E., Cauzzo, S., Bertoldo, A., & Antonini, A. (2026). Resting-state EEG changes associated with cognitive decline in Parkinson’s disease: a systematic review. Journal of Neural Transmission, 133(4), 731-765. https://doi.org/10.1007/s00702-025-03065-0
Vancouver
Spoa M, Monti S, Bjekić J, Guerra A, Fiorenzato E, Cauzzo S, et al. Resting-state EEG changes associated with cognitive decline in Parkinson’s disease: a systematic review. Journal of Neural Transmission. 2026;133(4):731-765. doi:10.1007/s00702-025-03065-0
BibTeX
@article{Spoa2026,
author = {Spoa, Milena and Monti, Sara and Bjekić, Jovana and Guerra, Andrea and Fiorenzato, Eleonora and Cauzzo, Simone and Bertoldo, Alessandra and Antonini, Angelo},
title = {Resting-state EEG changes associated with cognitive decline in Parkinson’s disease: a systematic review},
journal = {Journal of Neural Transmission},
year = {2026},
volume = {133},
number = {4},
pages = {731--765},
doi = {10.1007/s00702-025-03065-0}
}
EUVIMED